Menard Financial Group’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-3,948
| Closed | -$505K | – | 94 |
|
|
2022
Q1 | $505K | Buy |
3,948
+1,180
| +43% | +$151K | 0.5% | 59 |
|
|
2021
Q4 | $372K | Sell |
2,768
-236
| -8% | -$31.7K | 0.3% | 95 |
|
|
2021
Q3 | $411K | Buy |
3,004
+572
| +24% | +$78.3K | 0.36% | 87 |
|
|
2021
Q2 | $260K | Buy |
+2,432
| New | +$260K | 0.25% | 120 |
|
|
2020
Q4 | – | Sell |
-2,428
| Closed | -$250K | – | 144 |
|
|
2020
Q3 | $250K | Buy |
+2,428
| New | +$250K | 0.29% | 113 |
|